Understanding how genomic regulation affects health and disease
Official title: Center for Genomic Regulation
Funded at Oklahoma Medical Research Foundation · NIH-11019317 · Data updated 2026-11-12
This study is looking at how changes in our genes and how our cells divide can affect our health, and it's designed for researchers in Oklahoma who want to learn more and find new ways to help people with different diseases.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Oklahoma Medical Research Foundation NIH-funded |
| Lab location | 1 site (Oklahoma City, United States) |
| Project start | June 10, 2025 |
| Project end | April 30, 2030 |
| Funding year | 2025 |
| Award (this year) | $2,463,036 |
| NIH project number | 1P20GM156711-01 |
| Project ID | NIH-11019317 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals affected by diseases linked to genomic regulation issues, such as cancer or genetic disorders.
✕Less likely to help
Patients with conditions unrelated to genomic regulation or those not residing in the research area may not benefit from this research.
What this research studies
This research focuses on the regulation of genomic structure and function, which is crucial for maintaining health. It investigates how dysfunction in cell division, chromatin structure, and gene expression can lead to various human diseases. By leveraging advanced technologies and analytical methods in genomics, epigenomics, and transcriptomics, the project aims to create a collaborative research community in Oklahoma that fosters innovative studies and training in genomic regulation. The Center for Genomic Regulation will support early-stage investigators to enhance research capabilities and develop new interventions.
Why it matters
Potential benefit: If successful, this research could lead to new insights and interventions for diseases caused by genomic dysfunction.
How similar studies have gone: Previous research in genomic regulation has shown promise in understanding disease mechanisms and developing targeted therapies, indicating a strong potential for success in this area.
Where this research is happening
-
Oklahoma Medical Research Foundation
Oklahoma City, United States Active
Researchers
- Principal investigator: Freeman, Willard M — Oklahoma Medical Research Foundation
- Study coordinator: Freeman, Willard M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.